Panic Disorder

... EDP24 - Centre where people rebuild their lives STORY SEARCH The site where Norfolk really matters Friday, March 24, 2006 | 14:33 Home News Sport Business What's On Video news Text only About Us Art & Antiques Advertising Ad features Auctions Book reviews Calendars Cancer appeal Cards Classifieds Commentary Community Competitions Crosswords Dating Eating Out Environment EDP Norfolk Equestrian Directory Everything Directories ExPats Family Notices Farming News Farmers' Market Features Feedback Food Awards Forums Frontline Hidden Norfolk Homes & Gardens Info Desk Jobs Leisure Links Motors Next Big Thing Norfolk Roots Obituaries Photo Motors Photosales Postcard From Privacy Property Puppy Watch Quake Appeal Quizzes Reader Travel Recipes Reviews Search Shop Spooky Norfolk Sudoku Tourism Awards Walks Wedding Guide Your Photos 24 Your Rubbish Contact Us Privacy Terms Set as Homepage Text The Editor E-mail Alerts Desktop News How to use EDP24 Make EDP24 your homepage Contacts: EDP offices Telephone, email Deliveries Deliver the paper Subscribe: To the EDP and our range of magazines Advertise: Place your trade ad Newspapers Internet Leaflets Advertising features NEWS Centre where people rebuild their lives 24 March 2006 09:20 The atmosphere at Bridges is relaxed, informal and welcoming.The aim of this drop-in centre in Norwich is to help people with mental heal...

...Study Suggests Cymbalta(R) Significantly Reduces Core Anxiety Symptoms of Generalized Anxiety Disorder: Financial News - Yahoo!

Finance Yahoo!

My Yahoo!

Mail Welcome, Guest [Sign Out, My Account] Finance Home - Help HomeInvestingNews & CommentaryRetirement & PlanningBanking & CreditLoansTaxesSpecial EditionsColumnistsPersonal FinanceInvesting IdeasMarketsCompany FinancesProvidersGet QuotesSymbol LookupFinance Search Press ReleaseSource: Eli Lilly and Company Study Suggests Cymbalta(R) Significantly Reduces Core Anxiety Symptoms of Generalized Anxiety DisorderFriday March 24, 8:00 am ET Patients Taking Cymbalta Also Reported Reduced Painful Physical Symptoms and Improved Functioning MIAMI, March 24 /PRNewswire-FirstCall/ - A new study of approximately 500 patients evaluated the safety and efficacy of the antidepressant Cymbalta® (duloxetine HCl) on the core anxiety symptoms in patients with generalized anxiety disorder.

Cymbalta significantly reduced core anxiety symptoms and associated painful physical symptoms and improved functional impairment associated with the illness.

Results will be announced on Saturday, March 25, in two separate presentations(i,ii) at the Anxiety Disorders Association of America (ADAA) Annual Conference.

In this nine-week study, Cymbalta significantly improved core anxiety symptoms such as anxious mood, fears and tension by 51 percent in patients taking 60mg/day and by 50 percent in patients taking 120mg/day compared to an improvement of 3...

... PharmaLive: Study Suggests Cymbalta Significantly Reduces Core Anxiety Symptoms of Generalized Anxiety Disorder TRIAL RESULTS Study Suggests Cymbalta Significantly Reduces Core Anxiety Symptoms of Generalized Anxiety Disorder Patients Taking Cymbalta Also Reported Reduced Painful Physical Symptoms and Improved Functioning MIAMI, March 24, 2006 /PRNewswire-FirstCall via COMTEX News Network/ - A new study of approximately 500 patients evaluated the safety and efficacy of the antidepressant Cymbalta® (duloxetine HCl) on the core anxiety symptoms in patients with generalized anxiety disorder.

Cymbalta significantly reduced core anxiety symptoms and associated painful physical symptoms and improved functional impairment associated with the illness.

Results will be announced on Saturday, March 25, in two separate presentations(i,ii) at the Anxiety Disorders Association of America (ADAA) Annual Conference.

In this nine-week study, Cymbalta significantly improved core anxiety symptoms such as anxious mood, fears and tension by 51 percent in patients taking 60mg/day and by 50 percent in patients taking 120mg/day compared to an improvement of 32 percent in patients taking sugar pill.

Patients taking both 60mg/day and 120mg/day had significantly greater response and remission rates compared to patients taking sugar pill.

In addition, Cymbalta significantly reduced overall pain by 41 percent and 37 percent respectively, compared to 16 percent in patients taking sugar pill.

Cymbalta...